Sign inGet started

ADELMAN DANIEL C MD

Insider CIK 1222037 · AIMT Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1471,250$10.78 $768.1K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1470,000$14.87 $1.04M0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1456,250$0.43 $24.2K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-1452,500$10.69 $561.2K0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer deriv2020-10-132020-10-14135,068$23.05 $3.11M0SEC↗
AIMT Aimmune Therapeutics, Inc. D To issuer2020-10-132020-10-1422,343$34.50 $770.8K0SEC↗
AIMT Aimmune Therapeutics, Inc. U Tender2020-10-102020-10-1441,464$34.50 $1.43M0SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise deriv2020-10-022020-10-0534,932— $0135,068SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise2020-10-022020-10-0534,932$11.45 $400.0K63,807SEC↗
AIMT Aimmune Therapeutics, Inc. F Tax w/h2020-09-152020-09-16840$34.25 $28.8K28,875SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2020-05-102020-05-122,420— $029,715SEC↗
AIMT Aimmune Therapeutics, Inc. F Tax w/h2020-03-022020-03-041,872$23.81 $44.6K27,295SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2020-02-282020-03-0352,500— $052,500SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2020-02-282020-03-038,750— $029,167SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise deriv2020-01-022020-01-0320,000— $070,000SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2020-01-022020-01-0320,000$35.00 $700.0K21,250SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise2020-01-022020-01-0320,000$19.63 $392.6K41,250SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise deriv2019-12-092019-12-1120,000— $0170,000SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise2019-12-092019-12-1120,000$11.45 $229.0K41,250SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2019-12-092019-12-1120,000$30.04 $600.8K21,250SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2019-02-222019-02-2671,250— $071,250SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2019-02-222019-02-2611,875— $021,250SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2018-03-042018-03-0656,250— $056,250SEC↗
AIMT Aimmune Therapeutics, Inc. A Award2018-03-042018-03-069,375— $09,375SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise deriv2018-01-162018-01-169,933— $0190,000SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2018-01-162018-01-169,933$40.00 $397.3K0SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise2018-01-162018-01-169,933$11.45 $113.7K9,933SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise deriv2018-01-122018-01-1626,784— $0199,933SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2018-01-122018-01-1626,784$40.00 $1.07M0SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise2018-01-122018-01-1626,784$11.45 $306.7K26,784SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise deriv2017-12-272017-12-293,283— $0226,717SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2017-12-272017-12-293,283$40.00 $131.3K0SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise2017-12-272017-12-293,283$11.45 $37.6K3,283SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise deriv2017-10-232017-10-2510,000— $0230,000SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2017-10-232017-10-251,470$34.27 $50.4K3,000SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2017-10-232017-10-253,000$35.46 $106.4K0SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise2017-10-232017-10-2510,000$11.45 $114.5K10,000SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2017-10-232017-10-255,530$33.25 $183.9K4,470SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise deriv2017-09-252017-09-2710,000— $0240,000SEC↗
AIMT Aimmune Therapeutics, Inc. M Exercise2017-09-252017-09-2710,000$11.45 $114.5K10,000SEC↗
AIMT Aimmune Therapeutics, Inc. S Sale2017-09-252017-09-2710,000$25.00 $250.0K0SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2017-02-242017-02-2490,000— $090,000SEC↗
AIMT Aimmune Therapeutics, Inc. A Award deriv2016-06-242016-06-24250,000— $0250,000SEC↗